Literature DB >> 2823991

Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.

J C Stoof1, P F Verheijden, J E Leysen.   

Abstract

We compared some functional responses of D1- and D2-receptor stimulation in tissue slices of rat neostriatum with those in slices of the nucleus accumbens. In both brain regions D2-receptor stimulation inhibited the electrically evoked release of radiolabeled dopamine and acetylcholine. In both brain regions D1-receptor stimulation and forskolin increased the cyclic AMP formation. Only in the neostriatum, stimulation of D2-receptors inhibited the formation of cyclic AMP, brought about by forskolin or by D1-receptor stimulation. It is concluded from these experiments that, although functional responses of D2-receptor stimulation can be demonstrated in the nucleus accumbens, D2-receptors in this brain region are apparently uncoupled to adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823991     DOI: 10.1016/0006-8993(87)90864-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  Striatal dopamine in motor activation and reward-mediated learning: steps towards a unifying model.

Authors:  J Wickens
Journal:  J Neural Transm Gen Sect       Date:  1990

2.  Lack of effect of chronic desipramine treatment on dopaminergic activity in the nucleus accumbens of the rat.

Authors:  L Reyneke; R Allin; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1989-07       Impact factor: 3.996

3.  Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502.

Authors:  A M Murray; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors.

Authors:  K Wedzony; N Limberger; L Späth; T Wichmann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

5.  Dopamine and cyclic-AMP regulated phosphoprotein-32-dependent modulation of prefrontal cortical input and intercellular coupling in mouse accumbens spiny and aspiny neurons.

Authors:  S-P Onn; M Lin; J-J Liu; A A Grace
Journal:  Neuroscience       Date:  2007-11-28       Impact factor: 3.590

6.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

7.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

8.  Muscarinic cholinergic receptor-mediated modulation on striatal c-fos mRNA expression induced by levodopa in rat brain.

Authors:  H Chou; N Ogawa; M Asanuma; H Hirata; A Mori
Journal:  J Neural Transm Gen Sect       Date:  1992

9.  Mechanisms underlying presynaptic inhibition through alpha 2-adrenoceptors in guinea-pig submucosal neurones.

Authors:  K Z Shen; A Surprenant
Journal:  J Physiol       Date:  1990-12       Impact factor: 5.182

10.  Differential expression of autoreceptors in the ascending dopamine systems of the human brain.

Authors:  J H Meador-Woodruff; S P Damask; S J Watson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.